Insider Transactions Reported by 19 Insiders of MIRA PHARMACEUTICALS, INC.

Symbol
MIRA on Nasdaq
Location
Miami, FL

Insiders trading volume in the past year

MIRA PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Erez Aminov CEO and Chairman, Director $7,580,525 -$1,294,685 -15% 31 Dec 2025
Brian Patrick McNulty 10%+ Owner $4,998,529 28 Aug 2024
George Cappy 10%+ Owner $4,474,748 07 Aug 2023
Adam Kaplin Pres. & Chief Scientific Off. $310,820 02 Aug 2023
Bradley Kroenig Director $77,705 02 Aug 2023
Hugh McColl III Director $62,164 02 Aug 2023
David C. Vorhoff Director $62,164 02 Aug 2023
Talhia Tuck Director $31,082 02 Aug 2023
Denil Nanji Shekhat Director $30,210 01 Oct 2025
Christos Nicholoudis Director 17 Aug 2023
Matthew Paul Del Giudice Director 09 Dec 2024
Edward Clouston MacPherson Director 09 Dec 2024
Jerman A Michael Director 25 Mar 2024
Bay Shore Trust 10%+ Owner 15 Nov 2023
Michelle Yanez Chief Financial Officer 09 Dec 2024
Brian Frederick Daly Director 25 Oct 2023
Matthew Pratt Whalen Director 09 Dec 2024
Christopher C. Chapman JR Executive Chairman, Director 17 Aug 2023
Alan Weichselbaum Chief Financial Officer 15 May 2025

Recent Insider Transactions by Companies or Individuals for MIRA PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.